Sang-Mo Kang

Dr. Sang-Mo Kang is a Professor in the University of California, San Francisco (UCSF) School of Medicine, specializing in Transplant Surgery. He performs kidney, liver, and pancreas transplants while maintaining a research laboratory focused on transplant immunology to develop immune tolerance strategies that reduce reliance on immunosuppressive medications.

• Harvard Medical School (MD, 1992)
• UCSF (Surgical Residency and Transplant Fellowship)
• Howard Hughes Medical Institute Research Fellowships (NIH and UCSF Transplantation Research Laboratory)

Dr. Kang’s research spans:

• Immune system responses to transplanted organs
• Regulatory T cell (Treg) therapy for transplant tolerance
• Modified dendritic cell approaches for graft survival
• Techniques in laparoscopic donor surgeries
• Neural stem cell transplantation for rare genetic disorders

His publications reflect expertise in organ transplantation, immunology, and clinical surgical outcomes, with a focus on pediatric transplantation, graft survival, and innovative cell therapies. Funded by the National Institutes of Health and American Society of Transplant Surgeons, his work has been cited extensively in PubMed Central and Mendeley.

Scientific awards include:

• NIH grants for regulatory T cell therapies
• Howard Hughes Medical Institute fellowships
• American Society of Transplant Surgeons research funding

At UCSF, Dr. Kang mentors fellows, residents, and medical students, contributing to surgical education while advancing clinical practices in living donor transplantation and immune tolerance induction. His lab at UCSF investigates mechanisms of organ transplant rejection and develops novel strategies for long-term graft acceptance.